课题基金 / 基金详情

RIFAMPIN AND RIFABUTIN EFFECT ON COMBINATION ORAL CONTRACEPTIVES IN HIV PATIENTS

RIFAMPIN AND RIFABUTIN EFFECT ON COMBINATION ORAL CONTRACEPTIVES IN HIV PATIENTS
利福平和利福布丁对 HIV 患者联合口服避孕药的影响
批准号:
6114314
负责人:
PATRICIA A BARDITCH-CROVO
金额:
$2.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

PATRICIA A BARDITCH-CROVO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All evaluations have been completed for the study. Results show that both RIF and RBT resulted in significant reductions from baseline in mean EE2 area under the plasma concentration time curve (AUC) values. AUC's of NE also significantly decreased following RIF and RBT administrations. Maximum plasma concentrations (Cmax) of EE2 decreased significantly following RIF but not RBT administration. Cmax's of NE did not change significantly. When compared, RIF resulted in a significantly greater median percent decrease in the AUC's of both EE2 and NE (p's <0.05) and the Cmax's of EE2 (p < 0.05) than RBT. RIF resulted in a median percent increase of 38.9 [92.7] % in follicle stimulating hormone values suggesting a trend toward less suppression of the pituatary-gonadal axis. In spite of this finding, suppression of ovulation occurred in all subjects after taking RIF or RBT; plasma progesterone levels were less then 1.0 ng/ml in all subjects on day 21. The results of this study will be used by the FDA in consideration of amendments to the package labelling of RBT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II SEQUENTIAL COHORT 3 DOSE LEVELS OF ORAL ADEFOVIR DIPIVOXIL
  • 批准号:
    6114401
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
QUANTIFY RETENTION OF NONOXYNOL IN OPEN LABEL, RANDOMIZED CROSS OVER STUDY
  • 批准号:
    6114294
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
PHASE I/II ANTIVIRAL ACTIVITY OF 9R2, PROPYLADENINE (PMPA) IN HIV INFECTION
  • 批准号:
    6218234
  • 项目类别:
  • 资助金额:
    $0.23万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
PHASE I/II ANTIVIRAL ACTIVITY OF 9R2, PROPYLADENINE (PMPA) IN HIV INFECTION
  • 批准号:
    6297522
  • 项目类别:
  • 资助金额:
    $0.23万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
海外基金